(Q45398805)

English

In vivo oral administration effects of various oligodeoxynucleotides containing synthetic immunostimulatory motifs in the immune response to pseudorabies attenuated virus vaccine in newborn piglets

scientific article published on 20 November 2007

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

In vivo oral administration effects of various oligodeoxynucleotides containing synthetic immunostimulatory motifs in the immune response to pseudorabies attenuated virus vaccine in newborn piglets (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

attenuated vaccine

1 reference

based on heuristic

inferred from title

author name string

Zhang Linghua

1

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Tian Xingshan

2

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Zhou Fengzhen

3

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

language of work or name

0 references

publication date

20 November 2007

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

224-233

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Specific secretory immune responses in the female genital tract following intranasal immunization with a recombinant adenovirus expressing glycoprotein B of herpes simplex virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.058

7 January 2021

Mucosal immunity and tolerance: relevance to vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.058

7 January 2021

The mucosal immune system: from fundamental concepts to vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.058

7 January 2021

Mucosal immunity to infection with implications for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.058

7 January 2021

Synthetic oligonucleotides with particular base sequences from the cDNA encoding proteins of Mycobacterium bovis BCG induce interferons and activate natural killer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.058

7 January 2021

CpG motifs in bacterial DNA trigger direct B-cell activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.058

7 January 2021

An innate immune defense mechanism based on the recognition of CpG motifs in microbial DNA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.058

7 January 2021

CpG motifs in bacterial DNA and their immune effects

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.058

7 January 2021

CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.058

7 January 2021

Bacterial DNA induces murine interferon-gamma production by stimulation of interleukin-12 and tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.058

7 January 2021

Bacterial DNA-induced NK cell IFN-gamma production is dependent on macrophage secretion of IL-12

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.058

7 January 2021

Strategies for enhancing the immunostimulatory effects of CpG oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.058

7 January 2021

Response of porcine peripheral blood mononuclear cells to CpG-containing oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.058

7 January 2021

Identification of a sequence from the genome of porcine circovirus type 2 with an inhibitory effect on IFN- production by porcine PBMCs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.058

7 January 2021

Porcine-specific CpG-oligodeoxynucleotide activates B-cells and increases the expression of MHC-II molecules on lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.058

7 January 2021

CpG-oligodinucleotides as an effective adjuvant in pigs for intramuscular immunizations.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.058

7 January 2021

Effect of transgenic expression of porcine interleukin-6 gene and CpG sequences on immune responses of newborn piglets inoculated with Pseudorabies attenuated vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.058

7 January 2021

Co-administration of porcine-specific CpG oligodeoxynucleotide enhances the immune responses to pseudorabies attenuated virus vaccine in newborn piglets in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.058

7 January 2021

CpG oligodinucleotides induce strong humoral and cellular responses to swine streptococcic septicemia vaccine in piglets in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.058

7 January 2021

Induction of protective immunity in pigs after immunisation with CpG oligodeoxynucleotides formulated in a lipid-based delivery system (Biphasix?)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.058

7 January 2021

In vivo and in vitro tests showing sensitization to Japanese cedar (Cryptomeria japonica) pollen allergen in atopic dogs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.058

7 January 2021

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.058

7 January 2021

Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.058

7 January 2021

Binding immune-stimulating oligonucleotides to cationic peptides from viral core antigen enhances their potency as adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.058

7 January 2021

Immunotherapeutic uses of CpG oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.058

7 January 2021

Human papillomavirus virus-like particles are efficient oral immunogens when coadministered with Escherichia coli heat-labile enterotoxin mutant R192G or CpG DNA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.058

7 January 2021

Oral, intrarectal and intranasal immunizations using CpG and non-CpG oligodeoxynucleotides as adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.058

7 January 2021

CpG DNA is an effective oral adjuvant to protein antigens in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.058

7 January 2021

Oral pretreatment of mice with CpG DNA reduces susceptibility to oral or intraperitoneal challenge with virulent Listeria monocytogenes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.058

7 January 2021

Orally administered CpG oligodeoxynucleotide induces production of CXC and CC chemokines in the gastric mucosa and suppresses bacterial colonization in a mouse model of Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.058

7 January 2021

Interaction of antigens and antibodies at mucosal surfaces

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.058

7 January 2021

Local delivery of CpG oligodeoxynucleotides induces rapid changes in the genital mucosa and inhibits replication, but not entry, of herpes simplex virus type 2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.058

7 January 2021

Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.058

7 January 2021

Foreign (M13) DNA ingested by mice reaches peripheral leukocytes, spleen, and liver via the intestinal wall mucosa and can be covalently linked to mouse DNA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.058

7 January 2021

CpG motif identification for veterinary and laboratory species demonstrates that sequence recognition is highly conserved

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.058

7 January 2021

Human peripheral blood cells differentially recognize and respond to two distinct CPG motifs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.058

7 January 2021

Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.058

7 January 2021

Mechanism and function of a newly identified CpG DNA motif in human primary B cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.058

7 January 2021

Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.058

7 January 2021

Differential signaling by CpG DNA in DCs and B cells: not just TLR9

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.058

7 January 2021

The roles of Toll-like receptor 9, MyD88, and DNA-dependent protein kinase catalytic subunit in the effects of two distinct CpG DNAs on dendritic cell subsets

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.058

7 January 2021

Importance of CpG dinucleotides in activation of natural IFN-alpha-producing cells by a lupus-related oligodeoxynucleotide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.058

7 January 2021

Induction of specific immunoglobulin A in the small intestine, colon-rectum, and vagina measured by a new method for collection of secretions from local mucosal surfaces

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.058

7 January 2021

based on heuristic

inferred from DOI database lookup

Altering the cellular location of an antigen expressed by a DNA-based vaccine modulates the immune response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.058

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2007.10.058

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45398805&oldid=2087871453"